Stream 6 Session #4: Free communications- Pathophysiology of metabolic disease

Tracks
Meeting Room 111 & 112
Wednesday, August 19, 2026
11:00 AM - 12:30 PM
Meeting Room 111 & 112 (Level 1)

Speaker

Agenda Item Image
Prof Christopher Nolan
Endocrinologist
Canberra Health Services

Chairperson

Biography

Agenda Item Image
Prof Sarah Glastras
Endocrinologist
Northern Sydney Endocrine Centre

Chairperson

Biography

Agenda Item Image
Dr Ashwin Karuppan Vishwanathan
Medical Director
Tambaram Medical Center

BCSI-T2DA Novel β-Cell stress index to guide timely insulin initiation in Type 2 Diabetes

11:00 AM - 11:15 AM

Abstract

Biography

Dr. V. Ashwin Karuppan is a senior clinician with over 17 years of experience in internal medicine and diabetology. A Fellow of FRCP (Glasg),FCMA, and IDF, with international memberships (ACP, EASD), he has led 50+ research projects, published extensively, earned multiple awards, provided philanthropic care, and demonstrated sustained academic leadership
Agenda Item Image
Dr Xiuqi Qiao
Graduate student
Peking Union Medical College, Chinese Academy of Medical Sciences

5:2 Intermittent fasting with meal replacement improves TyG index and insulin resistance in early Type 2 Diabetes: A post hoc analysis of the EARLY trial

11:15 AM - 11:30 AM

Abstract

Biography

Qiao Xiuqi is a Ph.D. candidate at Peking Union Medical College. She has published five papers in Chinese core journals and seven SCI papers as the first author. Additionally, she has filed two patents as the primary inventor, with one already granted.
Agenda Item Image
Dr Cong Xie
Research Fellow
Adelaide University

The insulinotropic response to endogenous GIP in people with suboptimally controlled type 2 diabetes before and after 12 weeks of sitagliptin treatment

11:30 AM - 11:45 AM

Abstract

Biography

Dr Cong Xie is an early career post-doc at Adelaide University in research focusing on understanding the key role of the gut and taste signalling in glucose metabolism in both health and type 2 diabetes and the translation of these novel insights into improved therapy for type 2 diabetes.
Agenda Item Image
Dr Andrzej Januszewski
Senior Research Fellow
University of Sydney

Socioeconomic status modifies triglyceride-rich lipoprotein response to fenofibrate in the FIELD trial

11:45 AM - 12:00 PM

Abstract

Biography

Dr Andrzej Januszewski is a clinician-researcher at the University of Sydney focused on diabetes complications, insulin resistance, cardiovascular risk and biomarkers. His work integrates clinical trials, epidemiology and socioeconomic data to address health equity and access to care. He developed multiple online tools to improve risk prediction and doctor–patient communication.
Agenda Item Image
Dr Huu Thanh Le
Postdoctoral Fellowship
Westmead Institute for Medical Research

Multiplex immune monitoring predicts graft rejection in Porcine Islet Xenotransplantation

12:00 PM - 12:15 PM

Abstract

Biography

Dr Le earned his PhD from Western Sydney University in 2024 and is a postdoctoral fellow at the Westmead Institute. His research focuses on xeno-islet transplantation for type 1 diabetes. Supported by Breakthrough T1D and NHMRC, he has published internationally and won the 2025 WIMR Excellence Award and CPC grant.
Agenda Item Image
Dr Weikun Huang
Grant-funded Researcher
Adelaide University

Serum bile acid response to an oral glucose load is exaggerated in newly diagnosed, treatment-naive, Chinese with type 2 diabetes and reduced by insulin-pump therapy

12:15 PM - 12:30 PM

Abstract

Biography

Weikun is an early career researcher in multidisciplinary medical science, undertaking postdoctoral research training at Adelaide University. He has a unique interdisciplinary background across medicine, physics and material sciences, which has enabled me to develop novel research platforms, and embark on studies to understand metabolic derangement in major metabolic diseases.
loading